Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    51,779.32
    -376.75 (-0.72%)
     
  • CMC Crypto 200

    1,371.97
    +59.34 (+4.52%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Global Epigenetics Market to Reach $3.5 Billion by 2030

ReportLinker
ReportLinker

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, March 16, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Epigenetics Industry" - https://www.reportlinker.com/p05817986/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Epigenetics Market to Reach $3.5 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Epigenetics estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$3.5 Billion by 2030, growing at aCAGR of 12.7% over the period 2022-2030. KITS, one of the segments analyzed in the report, is projected to record 14.5% CAGR and reach US$1.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Reagents segment is readjusted to a revised 12.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $397.1 Million, While China is Forecast to Grow at 11.8% CAGR

The Epigenetics market in the U.S. is estimated at US$397.1 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$598.9 Million by the year 2030 trailing a CAGR of 11.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.5% and 9.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Select Competitors (Total 72 Featured)
- Abcam PLC
- Active Motif, Inc.
- CellCentric
- Diagenode SA
- Eisai Co., Ltd.
- F. Hoffmann-La Roche AG
- Illumina, Inc.
- MilliporeSigma
- Novartis International AG
- Oncolys BioPharma Inc.
- QIAGEN GmbH
- Syndax Pharmaceuticals, Inc.
- Thermo Fisher Scientific, Inc.
- Valirx Plc
- Zymo Research Corporation


Read the full report: https://www.reportlinker.com/p05817986/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Product Overview
Epigenetics: A Prelude
US to Dominate the Epigenetics Market
Epigenetics - Global Key Competitors Percentage Market Share in
2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Rising Prominence of Epigenetics Led Diagnostics
New Innovations and Techniques in Epigenetics
New Epigenetics Research Findings Creating Problems

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Epigenetics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 2: World Historic Review for Epigenetics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 3: World 16-Year Perspective for Epigenetics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Reagents by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 5: World Historic Review for Reagents by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 6: World 16-Year Perspective for Reagents by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for Kits
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2022 through 2030 and
% CAGR

Table 8: World Historic Review for Kits by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 9: World 16-Year Perspective for Kits by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Enzymes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 11: World Historic Review for Enzymes by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 12: World 16-Year Perspective for Enzymes by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for DNA
Methylation by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 14: World Historic Review for DNA Methylation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 15: World 16-Year Perspective for DNA Methylation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Histone Methylation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 17: World Historic Review for Histone Methylation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 18: World 16-Year Perspective for Histone Methylation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Histone Acetylation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 20: World Historic Review for Histone Acetylation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 21: World 16-Year Perspective for Histone Acetylation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Large Non - Coding RNA by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 23: World Historic Review for Large Non - Coding RNA by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 24: World 16-Year Perspective for Large Non - Coding RNA
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 25: World Recent Past, Current & Future Analysis for
MicroRNA Modification by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 26: World Historic Review for MicroRNA Modification by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 27: World 16-Year Perspective for MicroRNA Modification
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 28: World Recent Past, Current & Future Analysis for
Chromatin Structures by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 29: World Historic Review for Chromatin Structures by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 30: World 16-Year Perspective for Chromatin Structures by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 31: World Recent Past, Current & Future Analysis for
Oncology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 32: World Historic Review for Oncology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 33: World 16-Year Perspective for Oncology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 34: World Recent Past, Current & Future Analysis for
Instruments & Consumable by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 35: World Historic Review for Instruments & Consumable by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 36: World 16-Year Perspective for Instruments &
Consumable by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2014, 2023 & 2030

Table 37: World Recent Past, Current & Future Analysis for
Non-Oncology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 38: World Historic Review for Non-Oncology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 39: World 16-Year Perspective for Non-Oncology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 40: World Epigenetics Market Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
Epigenetics Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United States for 2023 (E)
Table 41: USA Recent Past, Current & Future Analysis for
Epigenetics by Product - Kits, Reagents, Enzymes and
Instruments & Consumable - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 42: USA Historic Review for Epigenetics by Product -
Kits, Reagents, Enzymes and Instruments & Consumable Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 43: USA 16-Year Perspective for Epigenetics by Product -
Percentage Breakdown of Value Sales for Kits, Reagents, Enzymes
and Instruments & Consumable for the Years 2014, 2023 & 2030

Table 44: USA Recent Past, Current & Future Analysis for
Epigenetics by Technology - DNA Methylation, Histone
Methylation, Histone Acetylation, Large Non - Coding RNA,
MicroRNA Modification and Chromatin Structures - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 45: USA Historic Review for Epigenetics by Technology -
DNA Methylation, Histone Methylation, Histone Acetylation,
Large Non - Coding RNA, MicroRNA Modification and Chromatin
Structures Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 46: USA 16-Year Perspective for Epigenetics by Technology -
Percentage Breakdown of Value Sales for DNA Methylation,
Histone Methylation, Histone Acetylation, Large Non - Coding
RNA, MicroRNA Modification and Chromatin Structures for the
Years 2014, 2023 & 2030

Table 47: USA Recent Past, Current & Future Analysis for
Epigenetics by Application - Oncology and Non-Oncology -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 48: USA Historic Review for Epigenetics by Application -
Oncology and Non-Oncology Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 49: USA 16-Year Perspective for Epigenetics by
Application - Percentage Breakdown of Value Sales for Oncology
and Non-Oncology for the Years 2014, 2023 & 2030

CANADA
Table 50: Canada Recent Past, Current & Future Analysis for
Epigenetics by Product - Kits, Reagents, Enzymes and
Instruments & Consumable - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 51: Canada Historic Review for Epigenetics by Product -
Kits, Reagents, Enzymes and Instruments & Consumable Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 52: Canada 16-Year Perspective for Epigenetics by Product -
Percentage Breakdown of Value Sales for Kits, Reagents,
Enzymes and Instruments & Consumable for the Years 2014, 2023 &
2030

Table 53: Canada Recent Past, Current & Future Analysis for
Epigenetics by Technology - DNA Methylation, Histone
Methylation, Histone Acetylation, Large Non - Coding RNA,
MicroRNA Modification and Chromatin Structures - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 54: Canada Historic Review for Epigenetics by Technology -
DNA Methylation, Histone Methylation, Histone Acetylation,
Large Non - Coding RNA, MicroRNA Modification and Chromatin
Structures Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 55: Canada 16-Year Perspective for Epigenetics by
Technology - Percentage Breakdown of Value Sales for DNA
Methylation, Histone Methylation, Histone Acetylation, Large
Non - Coding RNA, MicroRNA Modification and Chromatin
Structures for the Years 2014, 2023 & 2030

Table 56: Canada Recent Past, Current & Future Analysis for
Epigenetics by Application - Oncology and Non-Oncology -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 57: Canada Historic Review for Epigenetics by Application -
Oncology and Non-Oncology Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 58: Canada 16-Year Perspective for Epigenetics by
Application - Percentage Breakdown of Value Sales for Oncology
and Non-Oncology for the Years 2014, 2023 & 2030

JAPAN
Epigenetics Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Japan for 2023 (E)
Table 59: Japan Recent Past, Current & Future Analysis for
Epigenetics by Product - Kits, Reagents, Enzymes and
Instruments & Consumable - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 60: Japan Historic Review for Epigenetics by Product -
Kits, Reagents, Enzymes and Instruments & Consumable Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 61: Japan 16-Year Perspective for Epigenetics by Product -
Percentage Breakdown of Value Sales for Kits, Reagents,
Enzymes and Instruments & Consumable for the Years 2014, 2023 &
2030

Table 62: Japan Recent Past, Current & Future Analysis for
Epigenetics by Technology - DNA Methylation, Histone
Methylation, Histone Acetylation, Large Non - Coding RNA,
MicroRNA Modification and Chromatin Structures - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 63: Japan Historic Review for Epigenetics by Technology -
DNA Methylation, Histone Methylation, Histone Acetylation,
Large Non - Coding RNA, MicroRNA Modification and Chromatin
Structures Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 64: Japan 16-Year Perspective for Epigenetics by
Technology - Percentage Breakdown of Value Sales for DNA
Methylation, Histone Methylation, Histone Acetylation, Large
Non - Coding RNA, MicroRNA Modification and Chromatin
Structures for the Years 2014, 2023 & 2030

Table 65: Japan Recent Past, Current & Future Analysis for
Epigenetics by Application - Oncology and Non-Oncology -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 66: Japan Historic Review for Epigenetics by Application -
Oncology and Non-Oncology Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 67: Japan 16-Year Perspective for Epigenetics by
Application - Percentage Breakdown of Value Sales for Oncology
and Non-Oncology for the Years 2014, 2023 & 2030

CHINA
Epigenetics Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in China for 2023 (E)
Table 68: China Recent Past, Current & Future Analysis for
Epigenetics by Product - Kits, Reagents, Enzymes and
Instruments & Consumable - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 69: China Historic Review for Epigenetics by Product -
Kits, Reagents, Enzymes and Instruments & Consumable Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 70: China 16-Year Perspective for Epigenetics by Product -
Percentage Breakdown of Value Sales for Kits, Reagents,
Enzymes and Instruments & Consumable for the Years 2014, 2023 &
2030

Table 71: China Recent Past, Current & Future Analysis for
Epigenetics by Technology - DNA Methylation, Histone
Methylation, Histone Acetylation, Large Non - Coding RNA,
MicroRNA Modification and Chromatin Structures - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 72: China Historic Review for Epigenetics by Technology -
DNA Methylation, Histone Methylation, Histone Acetylation,
Large Non - Coding RNA, MicroRNA Modification and Chromatin
Structures Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 73: China 16-Year Perspective for Epigenetics by
Technology - Percentage Breakdown of Value Sales for DNA
Methylation, Histone Methylation, Histone Acetylation, Large
Non - Coding RNA, MicroRNA Modification and Chromatin
Structures for the Years 2014, 2023 & 2030

Table 74: China Recent Past, Current & Future Analysis for
Epigenetics by Application - Oncology and Non-Oncology -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 75: China Historic Review for Epigenetics by Application -
Oncology and Non-Oncology Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 76: China 16-Year Perspective for Epigenetics by
Application - Percentage Breakdown of Value Sales for Oncology
and Non-Oncology for the Years 2014, 2023 & 2030

EUROPE
Epigenetics Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Europe for 2023 (E)
Table 77: Europe Recent Past, Current & Future Analysis for
Epigenetics by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2022 through 2030 and % CAGR

Table 78: Europe Historic Review for Epigenetics by Geographic
Region - France, Germany, Italy, UK and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2014 through 2021 and % CAGR

Table 79: Europe 16-Year Perspective for Epigenetics by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2014, 2023 & 2030

Table 80: Europe Recent Past, Current & Future Analysis for
Epigenetics by Product - Kits, Reagents, Enzymes and
Instruments & Consumable - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 81: Europe Historic Review for Epigenetics by Product -
Kits, Reagents, Enzymes and Instruments & Consumable Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 82: Europe 16-Year Perspective for Epigenetics by Product -
Percentage Breakdown of Value Sales for Kits, Reagents,
Enzymes and Instruments & Consumable for the Years 2014, 2023 &
2030

Table 83: Europe Recent Past, Current & Future Analysis for
Epigenetics by Technology - DNA Methylation, Histone
Methylation, Histone Acetylation, Large Non - Coding RNA,
MicroRNA Modification and Chromatin Structures - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 84: Europe Historic Review for Epigenetics by Technology -
DNA Methylation, Histone Methylation, Histone Acetylation,
Large Non - Coding RNA, MicroRNA Modification and Chromatin
Structures Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 85: Europe 16-Year Perspective for Epigenetics by
Technology - Percentage Breakdown of Value Sales for DNA
Methylation, Histone Methylation, Histone Acetylation, Large
Non - Coding RNA, MicroRNA Modification and Chromatin
Structures for the Years 2014, 2023 & 2030

Table 86: Europe Recent Past, Current & Future Analysis for
Epigenetics by Application - Oncology and Non-Oncology -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 87: Europe Historic Review for Epigenetics by Application -
Oncology and Non-Oncology Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 88: Europe 16-Year Perspective for Epigenetics by
Application - Percentage Breakdown of Value Sales for Oncology
and Non-Oncology for the Years 2014, 2023 & 2030

FRANCE
Epigenetics Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in France for 2023 (E)
Table 89: France Recent Past, Current & Future Analysis for
Epigenetics by Product - Kits, Reagents, Enzymes and
Instruments & Consumable - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 90: France Historic Review for Epigenetics by Product -
Kits, Reagents, Enzymes and Instruments & Consumable Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 91: France 16-Year Perspective for Epigenetics by Product -
Percentage Breakdown of Value Sales for Kits, Reagents,
Enzymes and Instruments & Consumable for the Years 2014, 2023 &
2030

Table 92: France Recent Past, Current & Future Analysis for
Epigenetics by Technology - DNA Methylation, Histone
Methylation, Histone Acetylation, Large Non - Coding RNA,
MicroRNA Modification and Chromatin Structures - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 93: France Historic Review for Epigenetics by Technology -
DNA Methylation, Histone Methylation, Histone Acetylation,
Large Non - Coding RNA, MicroRNA Modification and Chromatin
Structures Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 94: France 16-Year Perspective for Epigenetics by
Technology - Percentage Breakdown of Value Sales for DNA
Methylation, Histone Methylation, Histone Acetylation, Large
Non - Coding RNA, MicroRNA Modification and Chromatin
Structures for the Years 2014, 2023 & 2030

Table 95: France Recent Past, Current & Future Analysis for
Epigenetics by Application - Oncology and Non-Oncology -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 96: France Historic Review for Epigenetics by Application -
Oncology and Non-Oncology Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 97: France 16-Year Perspective for Epigenetics by
Application - Percentage Breakdown of Value Sales for Oncology
and Non-Oncology for the Years 2014, 2023 & 2030

GERMANY
Epigenetics Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Germany for 2023 (E)
Table 98: Germany Recent Past, Current & Future Analysis for
Epigenetics by Product - Kits, Reagents, Enzymes and
Instruments & Consumable - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 99: Germany Historic Review for Epigenetics by Product -
Kits, Reagents, Enzymes and Instruments & Consumable Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 100: Germany 16-Year Perspective for Epigenetics by
Product - Percentage Breakdown of Value Sales for Kits,
Reagents, Enzymes and Instruments & Consumable for the Years
2014, 2023 & 2030

Table 101: Germany Recent Past, Current & Future Analysis for
Epigenetics by Technology - DNA Methylation, Histone
Methylation, Histone Acetylation, Large Non - Coding RNA,
MicroRNA Modification and Chromatin Structures - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 102: Germany Historic Review for Epigenetics by
Technology - DNA Methylation, Histone Methylation, Histone
Acetylation, Large Non - Coding RNA, MicroRNA Modification and
Chromatin Structures Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 103: Germany 16-Year Perspective for Epigenetics by
Technology - Percentage Breakdown of Value Sales for DNA
Methylation, Histone Methylation, Histone Acetylation, Large
Non - Coding RNA, MicroRNA Modification and Chromatin
Structures for the Years 2014, 2023 & 2030

Table 104: Germany Recent Past, Current & Future Analysis for
Epigenetics by Application - Oncology and Non-Oncology -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 105: Germany Historic Review for Epigenetics by
Application - Oncology and Non-Oncology Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR

Table 106: Germany 16-Year Perspective for Epigenetics by
Application - Percentage Breakdown of Value Sales for Oncology
and Non-Oncology for the Years 2014, 2023 & 2030

ITALY
Table 107: Italy Recent Past, Current & Future Analysis for
Epigenetics by Product - Kits, Reagents, Enzymes and
Instruments & Consumable - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 108: Italy Historic Review for Epigenetics by Product -
Kits, Reagents, Enzymes and Instruments & Consumable Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 109: Italy 16-Year Perspective for Epigenetics by Product -
Percentage Breakdown of Value Sales for Kits, Reagents,
Enzymes and Instruments & Consumable for the Years 2014, 2023 &
2030

Table 110: Italy Recent Past, Current & Future Analysis for
Epigenetics by Technology - DNA Methylation, Histone
Methylation, Histone Acetylation, Large Non - Coding RNA,
MicroRNA Modification and Chromatin Structures - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 111: Italy Historic Review for Epigenetics by Technology -
DNA Methylation, Histone Methylation, Histone Acetylation,
Large Non - Coding RNA, MicroRNA Modification and Chromatin
Structures Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 112: Italy 16-Year Perspective for Epigenetics by
Technology - Percentage Breakdown of Value Sales for DNA
Methylation, Histone Methylation, Histone Acetylation, Large
Non - Coding RNA, MicroRNA Modification and Chromatin
Structures for the Years 2014, 2023 & 2030

Table 113: Italy Recent Past, Current & Future Analysis for
Epigenetics by Application - Oncology and Non-Oncology -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 114: Italy Historic Review for Epigenetics by Application -
Oncology and Non-Oncology Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 115: Italy 16-Year Perspective for Epigenetics by
Application - Percentage Breakdown of Value Sales for Oncology
and Non-Oncology for the Years 2014, 2023 & 2030

UNITED KINGDOM
Epigenetics Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United Kingdom for 2023 (E)
Table 116: UK Recent Past, Current & Future Analysis for
Epigenetics by Product - Kits, Reagents, Enzymes and
Instruments & Consumable - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 117: UK Historic Review for Epigenetics by Product -
Kits, Reagents, Enzymes and Instruments & Consumable Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 118: UK 16-Year Perspective for Epigenetics by Product -
Percentage Breakdown of Value Sales for Kits, Reagents, Enzymes
and Instruments & Consumable for the Years 2014, 2023 & 2030

Table 119: UK Recent Past, Current & Future Analysis for
Epigenetics by Technology - DNA Methylation, Histone
Methylation, Histone Acetylation, Large Non - Coding RNA,
MicroRNA Modification and Chromatin Structures - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 120: UK Historic Review for Epigenetics by Technology -
DNA Methylation, Histone Methylation, Histone Acetylation,
Large Non - Coding RNA, MicroRNA Modification and Chromatin
Structures Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 121: UK 16-Year Perspective for Epigenetics by Technology -
Percentage Breakdown of Value Sales for DNA Methylation,
Histone Methylation, Histone Acetylation, Large Non - Coding
RNA, MicroRNA Modification and Chromatin Structures for the
Years 2014, 2023 & 2030

Table 122: UK Recent Past, Current & Future Analysis for
Epigenetics by Application - Oncology and Non-Oncology -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Table 123: UK Historic Review for Epigenetics by Application -
Oncology and Non-Oncology Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 124: UK 16-Year Perspective for Epigenetics by
Application - Percentage Breakdown of Value Sales for Oncology
and Non-Oncology for the Years 2014, 2023 & 2030

REST OF EUROPE
Table 125: Rest of Europe Recent Past, Current & Future
Analysis for Epigenetics by Product - Kits, Reagents, Enzymes
and Instruments & Consumable - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2022 through 2030 and %
CAGR

Table 126: Rest of Europe Historic Review for Epigenetics by
Product - Kits, Reagents, Enzymes and Instruments & Consumable
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 127: Rest of Europe 16-Year Perspective for Epigenetics
by Product - Percentage Breakdown of Value Sales for Kits,
Reagents, Enzymes and Instruments & Consumable for the Years
2014, 2023 & 2030

Table 128: Rest of Europe Recent Past, Current & Future
Analysis for Epigenetics by Technology - DNA Methylation,
Histone Methylation, Histone Acetylation, Large Non - Coding
RNA, MicroRNA Modification and Chromatin Structures -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05817986/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001